Eventus Diagnostics

About:

Eventus Diagnostics is developing a new class of blood tests that measure cancer-specific autoantibodies to diagnose cancer.

Website: http://eventusdx.com

Description:

Octava™ PinkEventus Diagnostics, Inc. (EventusDx) is an emerging life sciences company that is developing a new class of accurate and cost-effective blood tests that measure cancer-specific autoantibodies to diagnose cancer. The company’s first products, the Octava™ Pink and Octava™ Blue tests, provide additional information that enables women and their physicians to better assess the validity of their mammography screening results for the improved diagnosis of breast cancer.

Total Funding Amount:

$2.72M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2010-01-01

Contact Email:

general(AT)eventusdx.com

Founders:

Alon Hayka, Marvin M. Rosenberg

Number of Employees:

1-10

Last Funding Date:

2014-04-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai